Real world data (RWD) studies give us information about the functionality and efficacy of a medicine in the patient’s everyday life, which can be used, for example, to support pricing and reimbursement applications, development of pharmacotherapy support services, marketing of medicinal products or product development. Together with research pharmacies, we have carried out several real world data research projects, which have provided useful and up-to-date data.
“We execute many different projects and analyses of the real world data we collect. The purpose and use of the real world data in decision making has increased significantly, so it pays to invest in studies”, says Research Manager Jarno Ruotsalainen. Learn more about our Real world data services here.
These are some interesting examples from different therapeutic areas where we have carried out RWD projects:
The most well known of our research projects related to the treatment of diabetes is a large-scale follow-up study to map the effect of the changes in the reimbursement status of type 2 diabetes medicines. The study provides unique data on how diabetics have experienced the effects of the changes in the reimbursement status for diabetes medicines that came into force at the beginning of 2017.
The study was carried out in collaboration with the University of Eastern Finland and the HUS Endocrinology Outpatient Clinic.
Heli Salminen-Mankonen is happy to tell you more about the study.
In one large-scale project we collected data about the objectives of treating increased cholesterol levels, pharmacotherapy and matters associated with the execution of treatment from over a thousand patients with an increased risk of experiencing cardiovascular events. The study highlighted the factors affecting the adherence to and persistence of statin treatment, such as the effect of the negative tone used in the public discussion. Read the abstract of the study here.
The study was carried out in collaboration with Amgen.
Withdrawal from smoking
We have studied pharmacotherapy-assisted withdrawal from smoking in two projects. In the first project, we mapped the smoking habits of those who started on varenicline, and their previous attempts at quitting. In the follow-up study, we gathered information about the support and advice services designed for quitters.
Read the first publication from the study here. You can read the results from the follow-up study in the Finnish medical journal Suomen Lääkärilehti. Source: Laine J, Turunen J, Puumalainen I, Linden K. Varenikliinin käyttäjien tuki ja hoidon arkivaikuttavuus tupakasta vieroituksessa. Suomen Lääkärilehti 2017;33:1715-20.
The study was carried out in collaboration with Pfizer.
We investigated the use of methotrexate treatment and adherence among patients who use biological antirheumatic drugs. The results of the study have been published in Clinical and Experimental Rheumatology. Read the abstract here.
The study was carried out in collaboration with Roche.
Other therapeutic areas we have studied:
- Neuropathic pain
- Parkinson’s disease
- Multiple Sclerosis
- Overactive bladder
- Prostate cancer
- Hormonal contraception
Learn more about our Real world data services here.